Zacks.com on MSN15h
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome DrugSoleno's shares soar in the premarket hours following the FDA approval of Vykat XR (diazoxide choline) for treating ...
When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...
Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...
18h
FDA Approval of Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended De ...
Zacks Investment Research on MSN15h
IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to SobiIonis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive ...
Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session.
Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced significant progress in its nomlabofusp program for Friedreich’s ...
Vykat XR is specifically indicated to address hyperphagia, or the abnormally strong sensation of hunger, which often leads to ...
Psyllium husk is a powder that's rich in fiber, which is known to increase satiety and reduce appetite. Because it can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback